Growth Metrics

BioLineRx (BLRX) EPS (Basic) (QoQ) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 BioLineRx 9.32 Bn 9.30 Bn 154,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 94.53%
Sep 30, 2025 2.89%
Jun 30, 2025 20.15%
Mar 31, 2025 -9,262.51%
Dec 31, 2024 110.54%
Sep 30, 2024 96.97%
Jun 30, 2024 13.67%
Mar 31, 2024 -961.39%
Dec 31, 2023 50.00%
Sep 30, 2023 -200.00%
Jun 30, 2023 300.00%
Mar 31, 2023 -39.13%
Dec 31, 2022 28.12%
Sep 30, 2022 -200.00%
Jun 30, 2022 200.00%
Mar 31, 2022 -8.08%
Dec 31, 2021 7.47%
Sep 30, 2021 -200.00%
Jun 30, 2021 150.00%
Mar 31, 2021 50.00%
Dec 31, 2020 -100.00%
Sep 30, 2020 33.33%
Jun 30, 2020 25.00%
Mar 31, 2020 33.33%
Dec 31, 2019 -100.00%
Sep 30, 2019 -175.00%
Jun 30, 2019 180.00%
Mar 31, 2019 0.00%
Dec 31, 2018 16.67%
Sep 30, 2018 -20.00%
Jun 30, 2018 16.67%
Mar 31, 2018 14.29%
Dec 31, 2017 0.00%
Sep 30, 2017 -40.00%
Jun 30, 2017 37.50%
Mar 31, 2017 -14.29%
Dec 31, 2016 12.50%
Sep 30, 2016 -14.29%
Jun 30, 2016 -16.67%
Mar 31, 2016 23.10%
Dec 31, 2015 -3,201.33%
Sep 30, 2015 97.37%
Jun 30, 2015 10.89%
Mar 31, 2015 -86,447.48%
Jun 30, 2014 -1,400.00%
Mar 31, 2014 60.00%
Dec 31, 2013 0.00%
Sep 30, 2013 0.00%
Jun 30, 2013 0.00%